Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Inoue, T. Arai, M. Kitaichi, M. Akira, K. Nakata, R. Tazawa, J. Otsuka, M. Hirose, A. Matsumuro, M. Sakatani, Japanese Center of RLDC, Osaka Symposium on Respiratory Diseases (Sakai, Niigata, Japan). Intercurrent intractable factors in autoimmune pulmonary alveolar proteinosis. Eur Respir J 2009; 34: Suppl. 53, 757

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis Source: International Congress 2019 – CCC Airway diseases Year: 2019 Possible ocular involvement in pulmonary alveolar proteinosis Source: Eur Respir J 2006; 28: 456 Year: 2006 Our cases with pulmonary alveolar proteinosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 The role of apoptosis in idiopathic pulmonary alveolar proteinosis Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis Source: Eur Respir J, 49 (5) 1700407; 10.1183/13993003.00407-2017 Year: 2017 Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis Source: Eur Respir J, 49 (5) 1700178; 10.1183/13993003.00178-2017 Year: 2017 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 Comorbid interstitial lung diseases and collagen vascular diseases in pulmonary alveolar proteinosis: a nationwide surveillance in Japan Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis Source: Eur Respir J 2012; 39: 777-780 Year: 2012 Inhaled GM-CSF for autoimune pulmonary alveolar proteinosis Source: Short video statement 2020 Year: 2020 PAS-negative pulmonary alveolar proteinosis Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Surveillance of whole lung lavage for autoimmune pulmonary alveolar proteinosis in Japan Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Occupational and environmental impact on the clinical course of autoimmune pulmonary alveolar proteinosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Pulmonary alveolar proteinosis Source: Eur Respir Mon; 2009: 46: 208–224 Year: 2009 Pulmonary alveolar proteinosis Source: Eur Respir Rev 2011; 20: 98-107 Year: 2011 Lymphocytes populations in bloods and lungs in patients with auto-immune pulmonary alveolar proteinosis Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease Source: Eur Respir J 2009; 33: 1498-1502 Year: 2009